MENS NASDAQ
Jyong Biotech Ltd. Ordinary Shares
1W: +7.4%
1M: -3.1%
3M: -0.9%
YTD: -36.1%
1Y: -95.5%
$2.18
+0.15 (+7.39%)
Weekly Expected Move ±12.4%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$120K
+5.5% ▲
Operating Income
-$2M
+26.5% ▲
Net Income
-$3M
+31.4% ▲
EPS (Diluted)
$-0.04
+31.4% ▲
EBITDA
-$2M
+47.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $121K | $122K | $127K | $120K |
| Gross Profit | $0 | -$121K | -$122K | -$127K | -$120K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $2M | $2M | $1M | $1M | $927K |
| SG&A Expenses | $931K | $845K | $2M | $2M | $1M |
| Operating Expenses | $2M | $2M | $3M | $3M | $2M |
| Operating Income | -$2M | -$2M | -$3M | -$3M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $832K | $835K | $765K | $757K | $1M |
| Income Before Tax | -$2M | -$4M | -$7M | -$4M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$4M | -$7M | -$4M | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.03 | $-0.06 | $-0.09 | $-0.06 | $-0.04 |
| EBITDA | -$2M | -$3M | -$6M | -$4M | -$2M |
| Shares Outstanding | 72M | 76M | 76M | 76M | 76M |